费森尤斯医疗(FMS)今日盘中大跌6.84%，引发了市场的广泛关注。
消息面上，公司公布的第一季度财报显示，其核心的美国透析服务业务诊疗量出现下滑，同时业务重组产生的一次性成本拖累了净利润。具体而言，美国同市场诊疗量同比下降0.4%，公司称部分原因在于年初极端天气频发导致患者错失治疗。此外，公司为优化美国业务网络，计划关闭部分透析诊所，相关重组成本是导致一季度净利润从去年同期的1.51亿欧元降至1.18亿欧元的主要原因。
尽管营收在剔除汇率影响后同比增长3%，且公司维持了全年业绩指引不变，但诊疗量下滑和利润收窄的现状仍对投资者信心造成冲击，导致股价显著走低。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.